Accelerating immunological research with Dharmacon research tools and LentiBOOST technology

In this review, we examine specific case studies to illustrate how to accelerate discovery in Treg biology, immune signaling, and therapeutic development for autoimmune conditions using both LentiBOOST™ transduction enhancer and Dharmacon™ research reagents.

Explore real-world applications:

• Environmental modulation of T cell function through lncRNA regulation
• miRNA-mediated disruption of TGF-β signaling in multiple sclerosis
• Therapeutic rebalancing of immune homeostasis via Treg differentiation
• Next-generation chimeric TCR engineering for enhanced immunotherapy

You will learn about:

• High-efficiency gene modulation in traditionally challenging primary immune cells
• Precise manipulation of immune cell function
• Approaches for both mechanistic studies and translational research

Whether you're investigating autoimmune disease mechanisms or developing novel cell therapies, this resource provides key insights to help advance your research.

LentiBOOST Pharma-Grade technology and Dharmacon reagents:
For research use only. Not for use in diagnostic procedures.
LentiBOOST GMP Grade technology: Not for diagnostic use.
Other applications must be authorized by a license from Revvity.